Quality of early prostate cancer follow-up care from the patients’ perspective
Purpose To develop optimal cancer survivorship care programs, this study assessed the quality of prostate cancer follow-up care as experienced by patients shortly after completion of primary treatment. Methods We surveyed 402 patients with localized prostate cancer participating in a randomized controlled trial comparing specialist versus primary care–based follow-up. For the current study, we used patient-reported data at the time of the first follow-up visit at the hospital, prior to randomization. We assessed patients’ ratings of the quality of follow-up care using the Assessment of Patient Experiences of Cancer Care survey. This survey includes 13 scales about different aspects of care and an overall rating of care. Multivariable linear regression analysis was used to identify factors associated with perceived follow-up quality. Results Patients reported positive experiences at first follow-up for 9 of 13 scales, with mean (M) scores ranging from 79 to 97 (on a 0–100 response scale). Patients reported most frequently (over 70%) suboptimal care regarding symptom management (84%; M = 44, SD = 37), health promotion (75%; M = 45, SD = 39), and physician’s knowledge about patients’ life (84%; M = 65, SD = 23). Overall, patients’ lower quality of follow-up ratings were associated with younger age, higher education level, having more than one comorbid condition, having undergone primary surgery, and experiencing significant symptoms. Conclusion Patients with prostate cancer are generally positive about their initial, hospital-based follow-up care. However, efforts should be made to improve symptom management, health promotion, and physician’s knowledge about patients’ life. These findings point to areas where prostate cancer follow-up care can be improved..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:30 |
|---|---|
| Enthalten in: |
Supportive care in cancer - 30(2022), 12 vom: 28. Okt., Seite 10077-10087 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wollersheim, Barbara M. [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
Patient experiences |
|---|
| Anmerkungen: |
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
|---|
| doi: |
10.1007/s00520-022-07396-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2080093029 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2080093029 | ||
| 003 | DE-627 | ||
| 005 | 20230507080711.0 | ||
| 007 | tu | ||
| 008 | 230131s2022 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00520-022-07396-6 |2 doi | |
| 035 | |a (DE-627)OLC2080093029 | ||
| 035 | |a (DE-He213)s00520-022-07396-6-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 100 | 1 | |a Wollersheim, Barbara M. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Quality of early prostate cancer follow-up care from the patients’ perspective |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. | ||
| 520 | |a Purpose To develop optimal cancer survivorship care programs, this study assessed the quality of prostate cancer follow-up care as experienced by patients shortly after completion of primary treatment. Methods We surveyed 402 patients with localized prostate cancer participating in a randomized controlled trial comparing specialist versus primary care–based follow-up. For the current study, we used patient-reported data at the time of the first follow-up visit at the hospital, prior to randomization. We assessed patients’ ratings of the quality of follow-up care using the Assessment of Patient Experiences of Cancer Care survey. This survey includes 13 scales about different aspects of care and an overall rating of care. Multivariable linear regression analysis was used to identify factors associated with perceived follow-up quality. Results Patients reported positive experiences at first follow-up for 9 of 13 scales, with mean (M) scores ranging from 79 to 97 (on a 0–100 response scale). Patients reported most frequently (over 70%) suboptimal care regarding symptom management (84%; M = 44, SD = 37), health promotion (75%; M = 45, SD = 39), and physician’s knowledge about patients’ life (84%; M = 65, SD = 23). Overall, patients’ lower quality of follow-up ratings were associated with younger age, higher education level, having more than one comorbid condition, having undergone primary surgery, and experiencing significant symptoms. Conclusion Patients with prostate cancer are generally positive about their initial, hospital-based follow-up care. However, efforts should be made to improve symptom management, health promotion, and physician’s knowledge about patients’ life. These findings point to areas where prostate cancer follow-up care can be improved. | ||
| 650 | 4 | |a Quality of follow-up care | |
| 650 | 4 | |a Patients with prostate cancer | |
| 650 | 4 | |a Radical prostatectomy | |
| 650 | 4 | |a Radiation therapy | |
| 650 | 4 | |a Patient experiences | |
| 700 | 1 | |a van der Poel, Henk G. |4 aut | |
| 700 | 1 | |a van Asselt, Kristel M. |4 aut | |
| 700 | 1 | |a Pos, Floris J. |4 aut | |
| 700 | 1 | |a Tillier, Corinne N. |4 aut | |
| 700 | 1 | |a Akdemir, Emine |4 aut | |
| 700 | 1 | |a Vis, Andre N. |4 aut | |
| 700 | 1 | |a Lampe, Menuhin I. |4 aut | |
| 700 | 1 | |a van den Bergh, Roderick |4 aut | |
| 700 | 1 | |a Somford, Diederik M. |4 aut | |
| 700 | 1 | |a Knipscheer, Ben |4 aut | |
| 700 | 1 | |a Cauberg, Evelyne C. C. |4 aut | |
| 700 | 1 | |a Noordzij, Arjen |4 aut | |
| 700 | 1 | |a Aaronson, Neil K. |4 aut | |
| 700 | 1 | |a Boekhout, Annelies H. |4 aut | |
| 700 | 1 | |a van de Poll-Franse, Lonneke V. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Supportive care in cancer |d Springer Berlin Heidelberg, 1993 |g 30(2022), 12 vom: 28. Okt., Seite 10077-10087 |w (DE-627)170972038 |w (DE-600)1134446-5 |w (DE-576)032868545 |x 0941-4355 |7 nnns |
| 773 | 1 | 8 | |g volume:30 |g year:2022 |g number:12 |g day:28 |g month:10 |g pages:10077-10087 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s00520-022-07396-6 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_2018 | ||
| 912 | |a GBV_ILN_4277 | ||
| 951 | |a AR | ||
| 952 | |d 30 |j 2022 |e 12 |b 28 |c 10 |h 10077-10087 | ||